Omega Therapeutics Inc (OMGAQ)

Currency in USD
0.003
+0.001(+50.00%)
Closed·
OMGAQ Scorecard
Full Analysis
Operates with a significant debt burden
Trading near 52-week Low
OMGAQ is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0010.006
52 wk Range
0.0011.690
Key Statistics
Prev. Close
0.002
Open
0.006
Day's Range
0.001-0.006
52 wk Range
0.001-1.69
Volume
23.87K
Average Volume (3m)
398.46K
1-Year Change
-99.81%
Book Value / Share
0.21
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OMGAQ Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Omega Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Omega Therapeutics Inc Company Profile

Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company’s OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. It also develops OTX-2002 for hepatocellular carcinoma; OTX-2101 for non-small cell lung cancer; omega epigenomic controllers (OEC) for inflammatory lung diseases, such as neutrophilic asthma, acute respiratory distress syndrome, dermatological, oncology, and rheumatological indications; OEC candidates for idiopathic pulmonary fibrosis; liver regeneration medicines; and OEC candidates for patients with diabetes and other conditions to treat corneal epithelial injury. In addition, the company develops OEC candidates for the treatment of alopecia, a disorder characterized by patches of non-scarring hair loss affecting the scalp and body. Omega Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts. On February 10, 2025, Omega Therapeutics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Compare OMGAQ to Peers and Sector

Metrics to compare
OMGAQ
Peers
Sector
Relationship
P/E Ratio
0.0x−1.7x−0.5x
PEG Ratio
0.00−0.030.00
Price/Book
0.0x0.8x2.6x
Price / LTM Sales
0.0x41.5x3.3x
Upside (Analyst Target)
-246.8%43.5%
Fair Value Upside
Unlock34.8%6.8%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-- / -0.26
Revenue / Forecast
-- / 500.00K
EPS Revisions
Last 90 days

OMGAQ Income Statement

People Also Watch

1.270
QSI
-4.51%
18.23
SRPT
+1.50%
70.13
ABVX
+0.16%
7.460
HYPD
+35.64%
3.250
IMRX
-7.41%

FAQ

What Stock Exchange Does Omega Therapeutics Trade On?

Omega Therapeutics is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Omega Therapeutics?

The stock symbol for Omega Therapeutics is "OMGAQ."

What Is the Omega Therapeutics Market Cap?

As of today, Omega Therapeutics market cap is 166.10K.

What Is Omega Therapeutics's Earnings Per Share (TTM)?

The Omega Therapeutics EPS (TTM) is -1.33.

When Is the Next Omega Therapeutics Earnings Date?

Omega Therapeutics will release its next earnings report on 04 Nov 2025.

From a Technical Analysis Perspective, Is OMGAQ a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Omega Therapeutics Stock Split?

Omega Therapeutics has split 0 times.

How Many Employees Does Omega Therapeutics Have?

Omega Therapeutics has 94 employees.

What is the current trading status of Omega Therapeutics (OMGAQ)?

As of 09 Aug 2025, Omega Therapeutics (OMGAQ) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.01, while its 52-week range spans from 0.00 to 1.69.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.